KNSA
Kiniksa Pharmaceuticals, Ltd.
NASDAQ · BMHealthcareBiotechnology
$62.58-2.14%
Price as of Jul 20, 2026
KNSA analysis
Kiniksa Pharmaceuticals, Ltd. stock analysis
Published Drillr research and company-specific analysis. Existing articles keep their current URLs and citation behavior.
Analysis for KNSA is not published yet
Browse the public research library while company-specific analysis is being prepared. Explore research